It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: InachMarbank
a reply to: OccamsRazor04
Show me the numbers, not just words.
My experience tells me otherwise.
originally posted by: OccamsRazor04
a reply to: Wisenox
You can go with whatever you want, that's not evidence, and it would STILL not be gene therapy if it were true, which it's not because the evidence proves it's not.
Moderna has found a direction to volley their mountain of COVID-19 vaccine cash: gene editing.
Moderna is interested in new opportunities in nucleic acid technologies, gene therapy, gene editing and mRNA, CEO Stéphane Bancel said during the conference call. The company—which literally trades under the symbol MRNA—is also interested in new delivery technologies that could expand its existing mRNA work.
In his reply, Bourla mentioned future cancer drugs, but then also stated that mRNA vaccines could be used with people who are "born with a mistake in their DNA."